
Walking Juntos: Developing and Testing a Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors
Short Title: ALTE2321
Enrollment Status: Recruiting
NCT #: NCT06410209
Specialty Area: Pediatric Hematology/Oncology
Condition Studied: First diagnosis of malignant neoplasm
Age Groups: Child; Adult
Phase: II
Study Information
Summary / Purpose
The purpose of this study is to test a physical activity program to meet the unique needs of Hispanic or Latino/a adolescent and young adult cancer survivors. This physical activity program will take into account cultural and language preferences.
Who Can Participate
- Children and Adults 15 - 21 years of age
- First diagnosis of malignant neoplasm
- Must have completed all chemotherapy and/or radiation therapy in the last 3-36 months
- Self-report less than 420 minutes of physical activity per week
- Self-Identify as Hispanic/Latino
What's Involved
- Random assignment to one of two physical activity programs: wearing a Fitbit physical activity tracker only, or wearing a Fitbit plus additional support
- Wearing a Fitbit physical activity tracker daily to measure your activity levels
- For participants in the additional support group:
- Weekly goal-setting sessions with personalized physical activity goals
- Text messages and reminders
- Viewing and posting in a private social media peer support group
- Earning badges for your activity
- Completing questionnaires, including questions about your quality of life
- Completing an interview
Principal Investigator

Additional Information
Address: 1500 E 2nd St. Reno, NV 89502
General Research: 775-982-3646
Oncology Research: 775-982-5050
Email: Renown-CRD@renown.org
Complete Study Details: https://clinicaltrials.gov/study/NCT06410209
Disclaimer: This listing gives you general information about the study and isn't part of the official consent process. If you decide to learn more, the research team will talk with you and check if you meet any additional requirements to join the study.